The Board shall advise the Directors of CCR and DCEG, and the Director and Deputy Director, NCI, on a wide variety of matters concerning scientific program policy and progress and future direction of research programs in the areas of dermatology, metabolism, surgery, pathology, pediatrics, clinical pharmacology, clinical research, oncology, radiation oncology, radiation biology, biomarkers and prevention research.